This article is from the source 'rtcom' and was first published or seen on . It last changed over 40 days ago and won't be checked again for changes.

You can find the current article at its original source at https://www.rt.com/news/515696-southafrica-pretoria-covid19-vaccine-astrazeneca/

The article has changed 3 times. There is an RSS feed of changes available.

Version 1 Version 2
South Africa to share 1 million AstraZeneca Covid vaccine doses with continent as study says jab ineffective against local variant South Africa to share 1 million AstraZeneca Covid vaccine doses with continent as study says jab ineffective against local variant
(25 days later)
Pretoria has said it will share one million doses of AstraZeneca’s Covid-19 jab with other African countries via the African Union after the nation halted rollout of the UK-developed vaccine amid concerns over its effectiveness.Pretoria has said it will share one million doses of AstraZeneca’s Covid-19 jab with other African countries via the African Union after the nation halted rollout of the UK-developed vaccine amid concerns over its effectiveness.
Anban Pillay, the deputy director-general at the Department of Health, told Reuters on Tuesday that it is not true that Pretoria had tried to send 1 million doses of AstraZeneca’s Covid-19 vaccine back to the Serum Institute of India, where it was manufactured, but confirmed the country would offload the vaccines. Anban Pillay, the deputy director-general at the Department of Health, told Reuters on Tuesday that it is not true that Pretoria had tried to send 1 million doses of AstraZeneca’s Covid-19 vaccine back to the Serum Institute of India, where it was manufactured, but confirmed the country would offload the vaccines. 
“The doses are going to be shared with countries on the continent… via the AU (African Union),” Pillay said, adding that the country is looking to recover the money spent on the vaccines but hadn’t worked out how that would happen in practice.“The doses are going to be shared with countries on the continent… via the AU (African Union),” Pillay said, adding that the country is looking to recover the money spent on the vaccines but hadn’t worked out how that would happen in practice.
South Africa paused its rollout of the AstraZeneca jab earlier in February after a small study claimed that the vaccine was ineffective against the dominant strain of Covid-19 in the country. South Africa paused its rollout of the AstraZeneca jab earlier in February after a small study claimed that the vaccine was ineffective against the dominant strain of Covid-19 in the country. 
While none of the 2,000 study participants were hospitalized with severe symptoms or died, 39 eventually caught the virus – 19 from the vaccine group and 20 from the placebo group.While none of the 2,000 study participants were hospitalized with severe symptoms or died, 39 eventually caught the virus – 19 from the vaccine group and 20 from the placebo group.
AstraZeneca questioned the thoroughness of the study and said that while it has already started adapting its vaccine against the South African variant, it hopes that further studies will prove it to be effective in preventing severe cases caused by this and other variants of coronavirus.AstraZeneca questioned the thoroughness of the study and said that while it has already started adapting its vaccine against the South African variant, it hopes that further studies will prove it to be effective in preventing severe cases caused by this and other variants of coronavirus.
The African Union said it will still support the use of the jab despite efficacy concerns and its effectiveness against the South African variant. Around 100 million AstraZeneca vaccines are due to be delivered to the AU this year. The African Union said it will still support the use of the jab despite efficacy concerns and its effectiveness against the South African variant. Around 100 million AstraZeneca vaccines are due to be delivered to the AU this year. 
Instead, Pretoria plans to continue its inoculation campaign using Johnson & Johnson’s one-dose vaccine despite it not being used anywhere in world.The Johnson & Johnson vaccine will first be administered to healthcare workers as part of a trial next week. Instead, Pretoria plans to continue its inoculation campaign using Johnson & Johnson’s one-dose vaccine despite it not being used anywhere in world.The Johnson & Johnson vaccine will first be administered to healthcare workers as part of a trial next week. 
President Cyril Ramaphosa told lawmakers last week that the study aims to inoculate between 350,000 to 500,000 healthcare workers, with 80,000 jabs expected to arrive this week.President Cyril Ramaphosa told lawmakers last week that the study aims to inoculate between 350,000 to 500,000 healthcare workers, with 80,000 jabs expected to arrive this week.
If you like this story, share it with a friend!If you like this story, share it with a friend!
Dear readers and commenters,
We have implemented a new engine for our comment section. We hope the transition goes smoothly for all of you. Unfortunately, the comments made before the change have been lost due to a technical problem. We are working on restoring them, and hoping to see you fill up the comment section with new ones. You should still be able to log in to comment using your social-media profiles, but if you signed up under an RT profile before, you are invited to create a new profile with the new commenting system.
Sorry for the inconvenience, and looking forward to your future comments,
RT Team.